Clinical Trials Logo

Clinical Trial Summary

Xylitol and erythritol have become increasingly popular as sugar substitutes in the food industry. Both substances are freely available. While glucose ingestion stimulates satiation hormone secretion in the gut and slows down gastric emptying, artificial sweeteners such as aspartame, sucralose and acesulfame-K have no such effect. However, acute intake of 50g xylitol or 75g erythritol in 300mL tap water leads to a marked increase in the satiation hormones and induces a significant retardation in gastric emptying. The concentrations used to Show this effect were rather high (50g xylitol and 75g erythritol) and led to bloating and diarrhea in 60-70% of all subjects two hours after administration. The aim of the present study is to find an effective concentration of xylitol and erythritol still stimulating satiation hormone release without any gastrointestinal adverse events.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Physiological Satiation Mechanisms

NCT number NCT03039478
Study type Interventional
Source University Hospital, Basel, Switzerland
Contact
Status Completed
Phase N/A
Start date February 24, 2017
Completion date August 31, 2018

See also
  Status Clinical Trial Phase
Completed NCT04027283 - Acute Effects of the Two Alternative Sweeteners D-allulose and Erythritol on Metabolism N/A